A team from Massachusetts General Hospital (MGH) has created a novel contrast agent for MRI exams that may be safer than those requiring gadolinium. Matt O'Connor | Diagnostic Imaging | Health Imaging
Gadolinium-based contrast agents (GBCAs) are typically administered during follow-up imaging of multiple sclerosis (MS) patients. Michael Walter | Care Delivery | Radiology Business
Increased signal intensities in different brain regions presumably caused by linear and macrocyclic gadolinium-based contrast agents (GBCAs) could be an indication that gadolinium accumulation is more widespread than previously thought, according to a study presented on Wednesday at RSNA 2018. By Wayne Forrest, AuntMinnie.com staff writer
New findings are coming out on almost a weekly basis about trace elements of gadolinium left in human tissue after scans with MRI contrast agents. What do we know about this phenomenon, and how serious is it? We talk to Dr. Robert McDonald, PhD, of the Mayo Clinic in Rochester, MN.
GCG Global Healthcare are specialists in healthcare excellence. Driven by a desire to improve healthcare and clinical solutions for everyone – patients, medical professionals and facilities. Gloreen G at GCG has vast experience and understanding of the specialist medical and diagnostic imaging market. This gives GCG the ability to ensure that you receive the very best salary and incentives package, including leave entitlements, days off, paid conferences and radiology expenses.
Subscribe to our newsletter
LET US PROVIDE YOU WITH THE LATEST MEDICAL NEWS, NETWORKING AND PROFESSIONAL
DEVELOPMENT OPPORTUNITIES, AND EXCITING JOB OPENINGS FOR RADIOLOGISTS.
"*" indicates required fields
Find your next opportunity with GCG Global Healthcare TODAY!